Major Growth Driver Identified in 2025 Transfection Technologies Market: Growth In Gene Therapy Fuels Expansion Of The Transfection Technologies Market

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Transfection Technologies Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The market for transfection technologies has been expanding significantly in the past few years. Its size is expected to increase from $1.21 billion in 2024 to $1.31 billion in 2025, with a compound annual growth rate (CAGR) of 8.3%. The historic growth is due to factors like a higher incidence of chronic diseases, wider applications of transfection technologies, an escalating demand for cell and gene therapy, increased investments in research and development, and the rise in cancer cases.

Transfection Technologies Market Size Forecast: What's the Projected Valuation by 2029?
It is projected that the transfection technologies market will witness robust expansion in the forthcoming years, with its value expected to reach $1.83 billion in 2029, reflecting a compound annual growth rate (CAGR) of 8.8%. This anticipated growth in the forecast period can be ascribed to increasing incidences of chronic and immunological ailments, the escalating requirement for cell-oriented treatments, growing demand for protein production, rising investment and financial backing for the development of drug delivery mechanisms, and growing need for monoclonal antibodies. Key trends earmarked for the forecast period include heightened research and development in cell-based therapy, the adoption of cutting-edge transfection techniques, increasing demand for progressive therapeutic delivery systems, heightened usage of dual-reporter assays and co-transfection analysis, and a growing emphasis on individualized medicine.

View the full report here:
https://www.thebusinessresearchcompany.com/report/transfection-technologies-global-market-report

What Are the Drivers Transforming the Transfection Technologies Market?
The growth in the transfection technologies market is foreseen to surge with the advent of gene therapy. Gene therapy, a method aimed at disease prevention or treatment through gene modification-including the insertion, repair, or replacement of defective genes-has been gaining momentum. Its advancement is fuelled by progress in genetic research, improved delivery mechanisms, and its potential to cure previously untreatable genetic conditions. In the realm of gene therapy, transfection technologies play an indispensable role, ensuring the accurate, safe, and effective transfer of genetic material into cells. These technologies are instrumental in facilitating both temporary and permanent modifications in the genome, which proves crucial in the treatment of genetic disorders and cancers. As per a report by the American Society of Gene & Cell Therapy (ASGCT) and Citeline in July 2023, by the end of Q1 of 2023, there were 247 gene therapies in Phase II. This figure saw an increase of 5%, reaching 260 by the end of Q2. Hence, the upward trend in gene therapy is fuelling the growth of the transfection technologies market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19228&type=smp

What Are the Key Trends Driving Transfection Technologies Market Growth?
Major organizations in the transfection technologies market are stepping up their technological innovations, such as mechanoporation transfection systems. These systems intend to foster more specialized and personalized applications in the sectors of therapy and research. By applying mechanical forces, mechanoporation transfection systems generate temporary gaps in cellular membranes, facilitating the ingress of genetic matter into the cells. This approach is minimally intrusive and highly effective, hence safeguarding optimal cell viability. For example, a biotechnology firm based in Canada, STEMCELL Technologies, unleashed CellPore, a revolutionary transfection system in July 2024. The system comprises a benchtop unit and a CellPore Transfection Kit 300 equipped with a unique reagent kit and single-use delivery cartridges. CellPore uses controlled, quick deformation in microfluidic channels for the efficient transmission of small molecules, proteins, nucleic acids, and gene editing complexes into cells, thereby minimizing cell disruption and maximizing cell viability. These characteristics are instrumental for pushing forward research and for the formulation of state-of-the-art cell and gene treatments.

Which Segments in the Transfection Technologies Market Offer the Most Profit Potential?
The transfection technologies market covered in this report is segmented -

1) By Product: Kits And Reagents, Equipment, Other Products
2) By Transfection Method: Lipofection, Electroporation, Nucleofection, Cotransfection, Cationic Lipid Transfection, In-Vivo Transfection, Other Transfection Methods
3) By Application: Virus Production, Protein Production, Gene Silencing, Stem Cell Reprogramming And Differentiation, Stable Cell Line Generation, Therapeutic Delivery, Biomedical Research, Other Applications
4) By End-User: Pharmaceutical And Biotechnology Companies, Contract Research Organizations (CROs) And Contract Development And Manufacturing Organizations (CDMOs), Academic And Research Institutes, Other End-Users

Subsegments:
1) By Kits And Reagents: Transfection Kits, RNAi Reagents, DNA Reagents, Protein Transfection Reagents
2) By Equipment: Electroporation Devices, Microinjection Equipment, Lipofection Devices, Sonoporation Equipment
3) By Other Products: Transfection Software, Transfection Consumables, Custom Transfection Solutions

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=19228&type=smp

Which Firms Dominate the Transfection Technologies Market by Market Share and Revenue in 2025?
Major companies operating in the transfection technologies market are Thermo Fisher Scientific Inc., Lonza Group Ltd., Agilent Technologies Inc., Sartorius AG, Revvity Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Bio-Techne Corp., STEMCELL Technologies Inc., Promega Corporation, Takara Bio Inc., OriGene Technologies Inc., Applied Biological Materials Inc., MaxCyte Inc., New England Biolabs Inc., Cell Signaling Technology Inc., System Biosciences LLC, AMSBIO LLC, Altogen Biosystems, OZ Biosciences, Biontex Laboratories GmbH, RJH Biosciences Inc.

Which Regions Offer the Highest Growth Potential in the Transfection Technologies Market?
North America was the largest region in the transfection technologies market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the transfection technologies market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19228

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Speak With Our Expert: Saumya Sahay: Americas +1 310-496-7795: Asia +44 7882 955267 & +91 8897263534: Europe +44 7882 955267: Email: saumyas@tbrc.info: The Business Research Company - www.thebusinessresearchcompany.com: Follow Us On: LinkedIn: https://in.linkedin.com/company/the-business-research-company

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.